Eve Health Group Ltd
ASX:EVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (5.9), the stock would be worth AU$0.02 (47% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 11 | AU$0.03 |
0%
|
| 3-Year Average | 5.9 | AU$0.02 |
-47%
|
| 5-Year Average | 6.8 | AU$0.02 |
-38%
|
| Industry Average | 3.7 | AU$0.01 |
-66%
|
| Country Average | 5.8 | AU$0.02 |
-47%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Eve Health Group Ltd
ASX:EVE
|
8.5m AUD | 11 | -5.1 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 70 536.4 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
203.3B CHF | 6 | 22.5 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
78.7B USD | 8.8 | 32.1 | |
| FR |
|
Danone SA
PAR:BN
|
42.7B EUR | 3.5 | 23.5 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
47.6B ZAR | 4 | 12.5 | |
| US |
|
Hershey Co
NYSE:HSY
|
37B USD | 10.4 | 41.9 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
244.2B CNY | 14.5 | 25 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.1B ZAR | 4.7 | 12.8 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
225.7B CNY | 16.5 | 32.1 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.2B CHF | 6.5 | 31.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 3.4 |
| Median | 5.8 |
| 70th Percentile | 11.1 |
| Max | 27 768.2 |
Other Multiples
Eve Health Group Ltd
Glance View
EVE Health Group Ltd. engages in the investment in technology companies. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2004-04-08. The firm is engaged in agricultural operations located in northern New South Wales and the Meluka Honey business. The firm operates through two segments: Agriculture and Investment. The Company’s businesses include Meluka Australia Pty Ltd, Jenbrook Australia, Naturally Australian Products Inc. and Omni Innovation Pty Ltd. Meluka Health Pty Ltd provides retail health and wellness consumer products, including honey. Jenbrook Australia is a producer of organic tea tree and distributor of Australian botanical oils. Naturally Australian Products Inc. is a wholesaler of native Australian essential oils. Omni Innovation Pty Ltd. provides medical nutrition solutions for chronic and lifestyle diseases. The firm offers various products, including Raw Honey Probiotic Concentrate, Premium Tea Tree Essential Oil and organic honey products.
